1. Home
  2. GNW vs HAE Comparison

GNW vs HAE Comparison

Compare GNW & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genworth Financial Inc

GNW

Genworth Financial Inc

HOLD

Current Price

$8.52

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$74.81

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNW
HAE
Founded
1871
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.9B
IPO Year
2004
1991

Fundamental Metrics

Financial Performance
Metric
GNW
HAE
Price
$8.52
$74.81
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$10.00
$88.75
AVG Volume (30 Days)
3.9M
610.5K
Earning Date
02-23-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
160.86
42.54
EPS
0.52
3.44
Revenue
$7,299,000,000.00
$1,327,850,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.01
P/E Ratio
$14.47
$22.04
Revenue Growth
N/A
N/A
52 Week Low
$5.99
$47.32
52 Week High
$9.28
$87.32

Technical Indicators

Market Signals
Indicator
GNW
HAE
Relative Strength Index (RSI) 36.29 34.49
Support Level $8.41 $79.06
Resistance Level $9.12 $86.11
Average True Range (ATR) 0.19 2.26
MACD -0.08 -1.12
Stochastic Oscillator 12.18 1.70

Price Performance

Historical Comparison
GNW
HAE

About GNW Genworth Financial Inc

Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: